ACUMATCH 12/14 C-SERIES CEMENTED FEMORAL STEMS (SIZE 1-6), ACUMATCH 12/14 L-SERIES CEMENTED FEMORAL STEMS (SIZE 1-5)

K052787 · Exactech, Inc. · LZO · Dec 27, 2005 · Orthopedic

Device Facts

Record IDK052787
Device NameACUMATCH 12/14 C-SERIES CEMENTED FEMORAL STEMS (SIZE 1-6), ACUMATCH 12/14 L-SERIES CEMENTED FEMORAL STEMS (SIZE 1-5)
ApplicantExactech, Inc.
Product CodeLZO · Orthopedic
Decision DateDec 27, 2005
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 888.3353
Device ClassClass 2
AttributesTherapeutic

Intended Use

All Exactech Hip Systems are indicated for use in skeletally mature individuals undergoing primary surgery for hip replacement due to osteoarthritis, rheumatoid arthritis, osteonecrosis, post-traumatic degenerative problems of the hip, and for treatment of proximal femoral fractures where prosthetic replacement is determined by the surgeon as the preferred treatment. Components of Exactech Hip Systems are also potentially indicated for ankylosing spondylitis, congenital hip dysplasia, revision of failed previous reconstructions where sufficient bone stock is present, and to restore mobility resulting from previous fusion. Cemented femoral stems and cemented acetabular cups are intended for cemented fixation only. Press-fit femoral stems and acetabular cups are intended for press-fit fixation. Press-fit components without hydroxyapatite (HA) coating may also be used with bone cement at the discretion of the surgeon. Femoral heads and endoprostheses are intended for use in cemented and press-fit applications.

Device Story

AcuMatch and Novation Cemented Femoral Stems are orthopedic implants for hip arthroplasty. These devices replace the femoral head and neck to restore joint function. Modifications include transition to '12/14 Euro-Style' threadform tapers, adjusted neck lengths/geometry, and updated insertion hole features. L-Series stems transitioned from cast to forged Co-28Cr-6Mo. Novation stems feature modified cross-sectional geometry. Used by orthopedic surgeons in clinical settings for hip replacement procedures. Implants provide structural support and articulation for the hip joint, aiming to restore patient mobility and reduce pain. Performance verified via empirical testing and engineering analysis.

Clinical Evidence

Bench testing only. Engineering evaluations and empirical testing were conducted to verify that the performance of the modified femoral stems is adequate for anticipated in vivo use.

Technological Characteristics

Materials: Co-28Cr-6Mo (ASTM F75 cast or ASTM F799 forged). Design: Cemented femoral stems with 12/14 Euro-Style threadform taper. Features: Oblong insertion slot, laser-etched taper face, circulo-trapezoidal cross-section (Novation). Sterilization: Not specified.

Indications for Use

Indicated for skeletally mature individuals requiring primary hip replacement due to osteoarthritis, rheumatoid arthritis, osteonecrosis, post-traumatic degeneration, or proximal femoral fractures. Also indicated for ankylosing spondylitis, congenital hip dysplasia, and revision of failed reconstructions with sufficient bone stock. Contraindicated in patients with active infection, insufficient bone stock, neuromuscular disorders preventing joint control, or conditions expected to cause early implant failure.

Regulatory Classification

Identification

A hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis is a device intended to be implanted to replace a hip joint. This device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. The two-part femoral component consists of a femoral stem made of alloys to be fixed in the intramedullary canal of the femur by impaction with or without use of bone cement. The proximal end of the femoral stem is tapered with a surface that ensures positive locking with the spherical ceramic (aluminium oxide, A12 03 ) head of the femoral component. The acetabular component is made of ultra-high molecular weight polyethylene or ultra-high molecular weight polyethylene reinforced with nonporous metal alloys, and used with or without bone cement.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ## DEC 2 7 2005 2320 NW 66TH COURT GAINESVILLE, FL 32653 352 377-1140 FAX 352-378-2617 K052787 Exactech® Inc. AcuMatch 12/14 Cemented Femoral Stems Novation 12/14 Cemented Femoral Stems 510(k) Summary of Safety and Effectiveness Special 510(k) Exactech® Inc. Sponsor: 2320 N.W. 66th Court Gainesville, Florida 32653 | Phone: | (352) - 377 - 1140 | |--------|--------------------| | Fax: | (352) - 378 - 2617 | FDA Establishment Number 1038671 Bennie Gladdish Contact: Hip Systems Manager/Principal Engineer Date: September 27, 2005 Rev. 09/27/05 Section 4 Page 1 of 3 EXACTCH eight to inprove the politions by minibiling their octive ond integendence. We do this though innotive ides, high-quoting reduction on commitment to sense. {1}------------------------------------------------ 352 377-1140 FAX 352-378-2617 ### Exactech® Inc. AcuMatch 12/14 Cemented Femoral Stems Novation 12/14 Cemented Femoral Stems 510(k) Summary of Safety and Effectiveness Special 510(k) #### Trade or proprietary or model name(s): AcuMatch 12/14 C-Series Cemented Femoral Stems (Size 1-6) AcuMatch 12/14 L-Series Cemented Femoral Stems (Size 1-5) Novation Cemented Femoral Stems (Size 9,11,13,15,17) #### Information on devices to which substantial equivalence is claimed: | 510(k) | Trade or Proprietary or Model Name | Manufacturer | |---------|-----------------------------------------------------------|----------------| | Number | | | | K023646 | AcuMatch 12/14 C-Series Cemented Femoral Stems (Size 1-6) | Exactech, Inc. | | K001335 | AcuMatch 12/14 L-Series Cemented Femoral Stems (Size 2-5) | | | K011218 | AcuMatch 12/14 L-Series Cemented Femoral Stems (Size 1 ) | | #### INDICATIONS All Exactech Hip Systems are indicated for use in skeletally mature individuals undergoing primary surgery for hip replacement due to osteoarthritis, rheumatoid arthritis, osteonecrosis, post-traumatic degenerative problems of the hip, and for treatment of proximal femoral fractures where prosthetic replacement is determined by the surgeon as the preferred treatment. Components of Exactech Hip Systems are also potentially indicated for ankylosing spondylitis, congenital hip dysplasia, revision of failed previous reconstructions where sufficient bone stock is present, and to restore mobility resulting from previous fusion. - Cemented femoral stems and cemented acetabular cups are intended for . cemented fixation only. - Press-fit femoral stems and acetabular cups are intended for press-fit . fixation. Press-fit components without hydroxyapatite (HA) coating may also be used with bone cement at the discretion of the surgeon. - Femoral heads and endoprostheses are intended for use in cemented and . press-fit applications. #### Special 510(k) Modifications The AcuMatch 12/14 C-Series Cemented femoral stems were modified from the predicate as follows: - The femoral head/neck taper geometry was modified from Exactech's proprietary ● taper design to the "12/14 Euro-Style" threadform taper design Rev. 09/27/05 Section 4 Page 2 of 3 {2}------------------------------------------------ 352-377 1140 FAX 352-378-2617 ## Exactech® Inc. ## AcuMatch 12/14 Cemented Femoral Stems Novation 12/14 Cemented Femoral Stems 510(k) Summary of Safety and Effectiveness #### Special 510(k) - The femoral neck length was decreased by 4mm . - The femoral neck geometry was shifted medially by 1.5 mm . - The geometry of the insertion hole feature was modified from a dimple to the oblong . slot. - "12/14" Laser-etching was added to the face of the femoral stem taper . The AcuMatch 12/14 L-Series Cemented femoral stems were modified from the predicate as follows: - The femoral head/neck taper geometry was modified from Exactech's proprietary . taper design to the "12/14 Euro-Style" threadform taper design - . The femoral neck length was decreased by 4mm - The femoral neck geometry was shifted medially by 1.5 mm . - . The geometry of the insertion hole feature was modified from a dimple to the oblong slot. - . "12/14" Laser-etching was added to the face of the femoral stem taper. - A cobra flange geometry was added . - The material specifications for the L-Series cemented stem were changed from cast . Co-28Cr-6Mo (ASTM F75) to forged Co-28Cr-6Mo (ASTM F799). The Novation Cemented femoral stems were modified from the predicate as follows: - The femoral head/neck taper geometry was modified from Exactech's proprietary . taper design to a "12/14 Euro-Style" threadform taper design - . The trapezoidal cross-sectional area was modified to a circulo-trapezoidal geometry. - . A change to the sizing range and differential. - The insertion hole feature was changed from a spherical dimple to the oblong slot . - . A "12/14" Laser-etching was added to the face of the femoral stem taper. #### Conclusion: Testing and engineering evaluations were conducted to verify that the performance of the new Exactech AcuMatch 12/14 Cemented Femoral Stems and Novation Cemented Stems would be adequate for anticipated in vivo use. This includes empirical testing and engineering analyses. Based on successful results we conclude that the proposed devices are substantially equivalent to Exactech's predicate femoral stems. Rev. 09/27/05 Section 4 Page 3 of 3 {3}------------------------------------------------ Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo is circular and contains the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES . USA" around the perimeter. Inside the circle is a stylized symbol that resembles a human figure with three lines representing the head, body, and legs. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 DEC 2 7 2005 Ms. Maritza Elias Regulatory Representative Exactech, Inc. 2320 NW 66th Court Gainesville, Florida 32653 Re: K052787 Trade/Device Names: AcuMatch 12/14 Cemented Femoral Stems; Novation 12/14 Cemented Femoral Stems Regulation Number: 21 CFR 888.3353 Regulation Name: Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis Regulatory Class: II Product Codes: LZO, JDI Dated: November 22, 2005 Received: December 8, 2005 Dear Ms. Elias: We have reviewed your Section 510(k) premarket notification of intent to market the device we nave reviewed your bector 910(t) premised is substantially equivalent (for the indications felerenced above and nave determined ly marketed predicate devices marketed in interstate for use stated in the encreative to regars) the Medical Device Amendments, or to commerce prior to May 26, 1776, the enatinen with the provisions of the Federal Food, Drug, devices may been reculisomed in acces approval of a premarket approval application (PMA). and Cosmetic Act (Act) that do not require approval of a premarket approval applicat and Cosmetic Act (Act) that to not requests appt o the general controls provisions of the Act. The You may, therefore, manel me devices, seejeer to the more general controls provisions of the Act include requirements for annual registration, listing of general controls provisions of the rice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), in If your device is classified (sec above) me existing major regulations affecting your device can may be subject to such additional controls. Existing major regulation EDA m may be subject to such additional controller Entroller - British - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 800 to 898. In additio be found in the Ood of I cases on cerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that FDA s issualited of a bassaint in ther requirements of the Act that FDA has made a determination that your device complies with other must that FDA has made a delerimiation that Jour as roos by other Federal agencies. You must and listing and listing or any rederal statutes and regulations administrations of the registration and listing (21 left comply with an the Act stequirements, mercaing, and manufacturing practice requirements as set {4}------------------------------------------------ ## Page 2 – Ms. Maritza Elias forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic forth in the quality systems (QS) regulation (Sections 531-542 of the Act); 21 CFR 1000-1050. product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000- This letter will allow you to begin marketing your device as described in your Section 510(k) 1999) 1992 – 1992 – 1992 – 19 – 1 – 1 – 1 – 1 – 1 – 1 (x) I his letter will anow you to begin manxemily of substantial equivalence of your device to a legally premarket notification. The PDA mailing of substanted by and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please rs the results of the county of 1100 - All and assesses the regulation enti If you desire specific advice for your do not of the other note the regulation entitled, contact the Office of Complaned at (210) 210-01-21 (21CFR Part 807.97). You may obtain "Misbranding by relevence to premanon noutheations. other general information on your responsibilities under the Act from the 6800 638, 00 other general international and Consumer Assistance at its toll-free number (800) 638-2041 or Manufacturers, International and Consumer Assistanto at on on corn/industry/support/index.html. Sincerely yours, Signature a Mark N. Melkerson Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ # Exactech®, Inc. # AcuMatch 12/14 Cemented Femoral Stems Novation 12/14 Cemented Femoral Stems #### Indications for Use 510(k) Number: K052787 #### INDICATIONS All Exactech Hip Systems are indicated for use in skeletally mature individuals An Exactoon rip Dysterery for hip replacement due to osteoarthritis, rheumatoid andergoing primary as post-traumatic degenerative problems of the hip, and for treatment of proximal fractures where prosthetic replacement is determined by the surgeon as the preferred treatment. Components of Exactech Hip Systems are also the surgeon as the presentation spondylitis, congenital hip dysplasia, revision of potentially marcated structions where sufficient bone stock is present, and to restore mobility resulting from previous fusion. - Cemented femoral stems and cemented acetabular cups are intended for . cemented fixation only. - Press-fit femoral stems and acetabular cups are intended for press-fit . fixation. Press-fit components without hydroxyapatite (HA) coating may also be used with bone cement at the discretion of the surgeon. - Femoral heads and endoprostheses are intended for use in cemented and . press-fit applications. ### CONTRAINDICATIONS Exactech Hip Systems are contraindicated in patients with active infection, patients without sufficient bone stock to allow appropriate insertion and fixation of the prosthesis, without barneten over that do not allow control of the hip joint, and in patients m nouromasounar disoration marvel would cause the surgeon to expect early failure of the whose weight, ago, et unipolar and bipolar endoprostheses are also contraindicated for System: "The E Berrer anipes of degenerative changes in the acetabulum and/or pelvic fractures. Over the Counter Use or Prescription Use X Please do not write-below this line - use another page if needed. Concurrence of CDBA, Office of Device Evaluation (ODE) (Division Sign-Off) Division of General, Restorative, Section 3 09/27/05 and Neurological Devices Page 1 of 1 510(k) Numb
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%